GODREJAGRO - Godrej Agrovet Limited Share Price
Food Products
Valuation | |
|---|---|
| Market Cap | 15.69 kCr |
| Price/Earnings (Trailing) | 34.47 |
| Price/Sales (Trailing) | 1.62 |
| EV/EBITDA | 18.7 |
| Price/Free Cashflow | 21.07 |
| MarketCap/EBT | 29.18 |
| Enterprise Value | 16.94 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 9.43 kCr |
| Rev. Growth (Yr) | 11.3% |
| Earnings (TTM) | 403.37 Cr |
| Earnings Growth (Yr) | 13.1% |
Profitability | |
|---|---|
| Operating Margin | 5% |
| EBT Margin | 5% |
| Return on Equity | 15.5% |
| Return on Assets | 7.31% |
| Free Cashflow Yield | 4.75% |
Price to Sales Ratio
Revenue (Last 12 mths)
Net Income (Last 12 mths)
Growth & Returns | |
|---|---|
| Price Change 1W | -3.7% |
| Price Change 1M | 4.4% |
| Price Change 6M | 7.3% |
| Price Change 1Y | 1.5% |
| 3Y Cumulative Return | 18.1% |
| 5Y Cumulative Return | 11.9% |
| 7Y Cumulative Return | 3.5% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -81.53 Cr |
| Cash Flow from Operations (TTM) | 969.34 Cr |
| Cash Flow from Financing (TTM) | -900.84 Cr |
| Cash & Equivalents | 36.73 Cr |
| Free Cash Flow (TTM) | 744.67 Cr |
| Free Cash Flow/Share (TTM) | 38.73 |
Balance Sheet | |
|---|---|
| Total Assets | 5.52 kCr |
| Total Liabilities | 2.91 kCr |
| Shareholder Equity | 2.6 kCr |
| Current Assets | 2.19 kCr |
| Current Liabilities | 2.2 kCr |
| Net PPE | 2.5 kCr |
| Inventory | 1.26 kCr |
| Goodwill | 264.88 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.23 |
| Debt/Equity | 0.49 |
| Interest Coverage | 2.75 |
| Interest/Cashflow Ops | 8.27 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 11 |
| Dividend Yield | 1.35% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.10% |
Risk & Volatility | |
|---|---|
| Max Drawdown | -10.5% |
| Drawdown Prob. (30d, 5Y) | 31.15% |
| Risk Level (5Y) | 36.7% |
Summary of Latest Earnings Report from Godrej Agrovet
Summary of Godrej Agrovet's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Last updated:
Management's outlook for Godrej Agrovet Limited outlines an anticipated growth trajectory of 16% to 18% for both top-line and bottom-line in FY '26, primarily driven by volume growth across various business segments. The notable segments projected to contribute to this growth include Crop Protection, Animal Feed, and Astec LifeSciences.
Key forward-looking points include:
Astec LifeSciences: The segment is expected to recover with guidance indicating a 35% growth annually, supported by an increase in contract manufacturing. Management mentioned that the negative pricing pressures seen in previous periods have largely been resolved with high-cost inventory liquidation completed.
Animal Feed: Management anticipates sustained growth in this segment due to increased fish prices post a challenging year. EBIT per ton is forecasted to remain between INR 1,900 to INR 2,000 on average.
Crop Protection: The segment is set to benefit from product launches and expansion into new geographical markets. FY '26 margins are projected at 30%+, with potential for further improvement through innovative products.
Dairy Segment: The business unit aims for a volume growth of about 10% with a target to increase the salience of value-added products to over 40%. EBITDA margins are anticipated to improve to 6% to 7%.
Sustainability Efforts: The company remains focused on sustainability goals, achieving 81% energy consumption from renewable sources.
Management confirms they are proactively addressing past challenges, with a clear focus on operational efficiencies across all segments to ensure shareholder value creation and profitability enhancement in the coming years.
Last updated:
Q&A Section of the Godrej Agrovet Conference Call - May 5, 2025
Question 1: What are your thoughts on the Astec LifeSciences business over the next couple of years?
Answer: The challenges last year were mainly due to high-priced inventory. We have now liquidated this stock. In Q4, we've seen an improvement in volume offtake. By Q2, we expect normal demand from the U.S. and other geographies to return. Long-term, we're focusing on contract manufacturing, aiming for a 70-75% contribution to our business with new molecules launching by Q3.
Question 2: Can you share guidance on growth numbers for the contract manufacturing business?
Answer: We anticipate around 35% year-on-year growth in our contract manufacturing business over the next couple of years, building on a low base from last year.
Question 3: How should we think about gross margins in the enterprise business?
Answer: We expect gross margins to be around 12-14%. Some molecules will show 15-20% growth, but about 20-30% will remain under stress.
Question 4: What are the growth and profitability expectations across various segments for FY '26?
Answer: We are targeting a 16% to 18% top-line growth driven by volume, especially in Crop Protection, Animal Feed, and Astec LifeSciences. We aim for a similar profit increase, with significant gains from Astec reducing losses.
Question 5: What is the outlook for the dairy business and its margin?
Answer: We expect the dairy segment's overall volume growth to be around 10%. Value-added products will rise from 37% of sales to over 40% in FY '26, with EBITDA margins expanding from 5% to 6-7%.
Question 6: What has caused the margin compression in Dairy and Godrej Foods?
Answer: Margin compression stemmed from increased procurement costs for milk and chicken due to supply issues, particularly from bird flu. We expect gradual improvement in margins as markets stabilize.
Question 7: What about the outlook for the Vegetable Oil segment?
Answer: While prices are softening, we expect strong profitability driven by value-added products. Investments in refining will further enhance profitability, aiming for a more sustainable margin structure.
Question 8: Can you explain the impact of the fresh fruit bunch arrivals?
Answer: Fresh fruit bunch arrivals were lower in FY '25 but improved significantly by 11% in Q4. For FY '26, we anticipate an 18% growth in these arrivals, supporting our oil production.
Question 9: What should we expect in terms of margins for Astec in FY '26?
Answer: We expect to halve our losses this year, moving towards positive EBITDA. While the exact margin percentage is unclear right now, we are focused on driving profitability through improved volume and reduced costs.
Question 10: Regarding working capital, what changes are observed compared to previous years?
Answer: We've moved away from supplier financing due to high spreads, leading to increased payables and reduced inventories. This has resulted in enhanced working capital efficiency, which we aim to sustain moving forward.
Revenue Breakdown
Analysis of Godrej Agrovet's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Jun 30, 2025
| Description | Share | Value |
|---|---|---|
| Animal Feed | 42.6% | 1.2 kCr |
| Vegetable Oil | 18.4% | 499.1 Cr |
| Dairy | 15.4% | 416.8 Cr |
| Crop Protection Business | 14.8% | 402.6 Cr |
| Poultry and Processed Food | 6.9% | 186.9 Cr |
| Others | 1.9% | 51.9 Cr |
| Total | 2.7 kCr |
Share Holdings
Understand Godrej Agrovet ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
Holding Pattern
Share Holding Details
| Shareholder Name | Holding % |
|---|---|
| GODREJ INDUSTRIES LIMITED | 64.84% |
| V-SCIENCES INVESTMENTS PTE LTD | 3.1% |
| BALRAM SINGH YADAV | 1.75% |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMA | 1.2% |
| JAMSHYD GODREJ, PHEROZA GODREJ & NAVROZE GODREJ (TRUSTEES OF NAVROZE LINEAGE TRUST) | 1.08% |
| SMITA GODREJ CRISHNA, FREYAN CRISHNA BIERI, NYRIKA HOLKAR (TRUSTEES OF FVC FAMILY TRUST) | 1.08% |
| SMITA GODREJ CRISHNA, FREYAN CRISHNA BIERI, NYRIKA HOLKAR (TRUSTEES OF NVC FAMILY TRUST) | 1.08% |
| JAMSHYD GODREJ, PHEROZA GODREJ & NAVROZE GODREJ (TRUSTEES OF RAIKA LINEAGE TRUST) | 1.08% |
| NADIR GODREJ, HORMAZD GODREJ & RATI GODREJ (TRUSTEES OF HNG FAMILY TRUST) | 0.45% |
| NISABA GODREJ & PIROJSHA GODREJ (TRUSTEES OF NG FAMILY TRUST) | 0.45% |
| NADIR GODREJ, HORMAZD GODREJ & RATI GODREJ (TRUSTEES OF BNG FAMILY TRUST) | 0.45% |
| NADIR GODREJ, HORMAZD GODREJ & RATI GODREJ (TRUSTEES OF SNG FAMILY TRUST) | 0.45% |
| PIROJSHA ADI GODREJ | 0.36% |
| TANYA DUBASH AND PIROJSHA GODREJ (TRUSTEES OF TAD FAMILY TRUST) | 0.31% |
| TANYA ARVIND DUBASH | 0.14% |
| KARLA BOOKMAN | 0.05% |
| SASHA GODREJ | 0.05% |
| RATI NADIR GODREJ | 0% |
| BURJIS NADIR GODREJ | 0% |
| SOHRAB NADIR GODREJ | 0% |
Overall Distribution
Distribution across major stakeholders
Ownership Distribution
Distribution across major institutional holders
Is Godrej Agrovet Better than it's peers?
Detailed comparison of Godrej Agrovet against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| PIIND | PI Industries | 61.28 kCr | 8.32 kCr | -2.60% | -8.70% | 36.91 | 7.36 | - | - |
| UPL | UPL | 59.68 kCr | 47.32 kCr | +5.00% | +29.30% | 52.28 | 1.26 | - | - |
| RALLIS | Rallis India | 7.1 kCr | 2.88 kCr | +15.60% | +0.40% | 41.38 | 2.47 | - | - |
| KSCL | Kaveri Seed Co. | 5.64 kCr | 1.25 kCr | -9.40% | +4.20% | 19.9 | 4.51 | - | - |
Sector Comparison: GODREJAGRO vs Food Products
Comprehensive comparison against sector averages
Comparative Metrics
GODREJAGRO metrics compared to Food
| Category | GODREJAGRO | Food |
|---|---|---|
| PE | 34.47 | 36.13 |
| PS | 1.62 | 2.73 |
| Growth | 2.7 % | 6.3 % |
Performance Comparison
GODREJAGRO vs Food (2021 - 2025)
- 1. GODREJAGRO is among the Top 5 Food Products companies by market cap.
- 2. The company holds a market share of 7.1% in Food Products.
- 3. In last one year, the company has had a below average growth that other Food Products companies.
Income Statement for Godrej Agrovet
Balance Sheet for Godrej Agrovet
Cash Flow for Godrej Agrovet
What does Godrej Agrovet Limited do?
Godrej Agrovet Limited, an agri-business company, provides products and services that enhance crop and livestock yields in India and internationally. The company operates through Animal Feed, Vegetable Oil, Crop Protection, Dairy, Poultry and Processed Food, and Other segments. It offers animal feed, such as cattle, poultry, and aqua feed. In addition, the company engages in the oil palm cultivation with approximately 75,000 hectares of plantations across Andhra Pradesh, Telangana, Tamil Nadu, Goa, Maharashtra, and Mizoram producing crude palm oil, crude palm kernel oil, and palm kernel cake. Further, it produces and markets crop protection products, including plant growth regulators, organic manures, bio-stimulants, crop protection chemicals, herbicides, and homobrassinolides. Additionally, the company manufactures and markets poultry and meat products under the Real Good Chicken name; vegetarian and non-vegetarian ready-to-cook products under the Godrej Yummiez name; and processes and sells milk and milk products under the Godrej Jersey brand. Furthermore, it produces agrochemical active ingredients, intermediates, bulk and formulations, and pharmaceutical intermediates. Godrej Agrovet Limited was incorporated in 1991 and is based in Mumbai, India. The company is a subsidiary of Godrej Industries Limited.